Omeros Corporation (OMER) Stock

Omeros Corporation (OMER) is a Healthcare stock trading at $10.23 (as of 2026-06-18), with a market capitalization of $799.02M and a trailing P/E of 9.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Omeros Corporation is a commercial-stage biopharmaceutical company that discovers, develops, and commercializes small-molecule and protein therapeutics. Its programs address inflammation, complement-mediated diseases, immune-system-related cancers, and addictive and compulsive disorders, including clinical-stage candidates such as narsoplimab and OMS405.

Valuation — source: SEC EDGAR (first-party)
Price$10.23
Market Cap$799.02M
P/E Ratio9.6
EV / EBITDA-8.5
Price / Book-12.62
Price / Sales80.77
DCF Value (model)$-28.55
DCF Upside vs Price-378.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$2.30M
Net Margin-145.7%
Return on Equity-136.1%
Debt / Equity-1.39
Current Ratio3.03
Revenue Growth (YoY)-72.6%
EPS Growth (YoY)-98.1%
FCF Growth (YoY)-22.0%
Financial Health — source: SEC EDGAR
Altman Z-Score-3.67 (distress)
Valuation vs Sector & Industry
Stock P/E9.6
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-54.2%
vs Industry-44.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($68.93M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOGregory A. Demopulos
Employees202
CountryUS
IPO Date2009-10-08

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Schrödinger, Inc. (SDGR)
  • Palvella Therapeutics, Inc. (PVLA)
  • Septerna, Inc. (SEPN)
  • Savara Inc. (SVRA)
  • Amphastar Pharmaceuticals, Inc. (AMPH)
  • Phathom Pharmaceuticals, Inc. (PHAT)
  • ARS Pharmaceuticals, Inc. (SPRY)
  • Inhibrx Biosciences, Inc. (INBX)
OMER earnings history · OMER institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.